GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Enzymatica AB (XSAT:ENZY) » Definitions » Other Operating Expense

Enzymatica AB (XSAT:ENZY) Other Operating Expense : kr-3.52 Mil (TTM As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Enzymatica AB Other Operating Expense?

Enzymatica AB's Other Operating Expense for the three months ended in Mar. 2024 was kr-0.53 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 was kr-3.52 Mil.

Enzymatica AB's quarterly Other Operating Expense declined from Sep. 2023 (kr-0.24 Mil) to Dec. 2023 (kr-2.35 Mil) but then increased from Dec. 2023 (kr-2.35 Mil) to Mar. 2024 (kr-0.53 Mil).

Enzymatica AB's annual Other Operating Expense declined from Dec. 2021 (kr-1.04 Mil) to Dec. 2022 (kr-1.33 Mil) and declined from Dec. 2022 (kr-1.33 Mil) to Dec. 2023 (kr-3.17 Mil).


Enzymatica AB Other Operating Expense Historical Data

The historical data trend for Enzymatica AB's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enzymatica AB Other Operating Expense Chart

Enzymatica AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1.08 -0.99 -1.04 -1.33 -3.17

Enzymatica AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.18 -0.40 -0.24 -2.35 -0.53

Enzymatica AB Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was kr-3.52 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Enzymatica AB Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Enzymatica AB's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Enzymatica AB (XSAT:ENZY) Business Description

Traded in Other Exchanges
Address
Scheelevagen 19, Delta 5, Ideon Science Park, Lund, SWE, SE-223 70
Enzymatica AB is a life science company that develops and sells medical devices against infectious diseases, based on a barrier technology, which includes marine enzymes. Its product ColdZyme Mouth Spray prevents cold and reduces disease period.

Enzymatica AB (XSAT:ENZY) Headlines

From GuruFocus

Julian Robertson Cuts Half of Stake in Paulson-Backed Company

By Holly LaFon Holly LaFon 07-01-2016

Tiger Management Founder Julian Robertson Ups Stake in Enzymotec

By Kyle Ferguson Kyle Ferguson 12-07-2015

Julian Robertson Adds to Multiple Positions in 3rd quarter

By Tiziano Frateschi Tiziano Frateschi 12-20-2016